Health and life sciences investing experts Chris Wood and Jake Weber seek out small-cap biotech pioneers with the potential to become the medical sensations of tomorrow, viewed through the C.A.S.H. investing lens (Catalyst, Addressable Market, Science, and Hype Potential).
Learn More